Skip to main content
OpenTrials
Completed

NCT Number: NCT04790071

Dry Needling Treatment in Hemiplegic Shoulder Pain

To evaluate the efficacy of dry needling therapy on shoulder pain and upper extremity functions in hemiplegic patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kars State Hosital, Kars, Turkey (Türkiye)

Loading trial locations.

About this study

The myofascial trigger point is an overlooked issue in hemiplegic shoulder pain. Our aim in this study is to evaluate whether dry needling treatment contributes to the conventional treatment approach.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patients included in the study were aged between 30-60 years, with at least a 3-month history of hemorrhagic or ischemic stroke.

Exclusion criteria

  • if they had severe difficulty in communication
  • had received a corticosteroid injection within 3 months prior to enrollment
  • had bleeding diathesis, a history of shoulder surgery
  • a preexisting painful shoulder disorder, or had a cardiac pacemaker.

Treatment and study plan

Conventional physical therapy

Other

Conventional physical therapy: The patients received physical therapy to the shoulder, transcutaneous electrical nerve stimulation, and stretching and strengthening exercises (5 days per week for three weeks in a total of 15 sessions).

Conventional physical therapy plus dry needling

Other

Conventional physical therapy plus dry needling: The patients received physical therapy to the shoulder, including transcutaneous electrical nerve stimulation, stretching, and strengthening exercise (5 days per week for three weeks in a total of 15 sessions). And also, a total of 3 dry needling sessions were applied at 7-day intervals.

Primary outcomes

  1. Change in visual analog scale score

    Time frame: 3 months

    It grades pain of the patients between 0 and 10 points. Higher scores represent a worse outcome

  2. Change in range of motion

    Time frame: 3 months

    Shoulder range of motion of the patients is evaluated in abduction, flexion, and external rotation. Higher measurements represent a better outcome

  3. Change in Quick The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire score

    Time frame: 3 months

    The Quick DASH is an 11-item measure of the magnitude of disability and symptoms specific to the upper extremity. The first 6 items measure the degree of difficulty in performing various physical activities because of a shoulder, arm, and hand problem, and the other 5 items related to quality of sleeping, social activities, and daily activities, and the intensity of pain and numbness.

  4. Change in Fugl-Meyer Assessment score

    Time frame: 3 months

    The FM scale is a 226-point multi-item Likert-type scale developed as an evaluative measure of recovery from hemiplegic stroke. It is divided into 5 domains: motor function, sensory function, balance, joint range of motion, and joint pain. Each domain contains multiple items, each scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully).

Sponsors and collaborators

Lead sponsor

Kars State Hospital

Other

Registry information

Official study title

Does Dry Needling Treatment Make an Extra Contribution to Conventional Treatment in Hemiplegic Shoulder Pain?

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 10, 2021
Registry last updated
Jun 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.